The T-cell inhibitory molecule butyrophilin-like 2 is up-regulated in mild plasmodium falciparum infection and is protective during experimental cerebral malaria

Krishanthi S. Subramaniam, Emily Spaulding, Emil Ivan, Eugene Mutimura, Ryung S. Kim, Xikui Liu, Chen Dong, Catherine M. Feintuch, Xingxing Zhang, Kathryn Anastos, Gregoire Lauvau, Johanna P. Daily

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Plasmodium falciparum infection can result in severe disease that is associated with elevated inflammation and vital organ dysfunction; however, malaria-endemic residents gain protection from lethal outcomes and manifest only mild symptoms during infection. To characterize host responses associated with this more effective antimalarial response, we characterized whole-blood transcriptional profiles in Rwandan adults during a mild malaria episode and compared them with findings from a convalescence sample. We observed transcriptional up-regulation in many pathways, including type I interferon, interferon γ, complement activation, and nitric oxide during malaria infection, which provide benchmarks of mild disease physiology. Transcripts encoding negative regulators of T-cell activation, such as programmed death ligand 1 (PD-L1), programmed death 1 ligand 2 (PD-L2), and the butyrophilin family member butyrophilin-like 2 (BTNL2) were also increased. To support an important functional role for BTNL2 during malaria infection, we studied chimeric mice reconstituted with BTNL2-/- or wild-type hematopoietic cells that were inoculated with Plasmodium berghei ANKA, a murine model of cerebral malaria. We found that BTNL2-/- chimeric mice had a significant decrease in survival compared with wild-type counterparts. Collectively these data characterize the immune responses associated with mild malaria and uncover a novel role for BTNL2 in the host response to malaria.

Original languageEnglish (US)
Pages (from-to)1322-1331
Number of pages10
JournalJournal of Infectious Diseases
Volume212
Issue number8
DOIs
StatePublished - Oct 15 2015

Fingerprint

Cerebral Malaria
Plasmodium falciparum
Malaria
T-Lymphocytes
Infection
Ligands
Plasmodium berghei
Benchmarking
Interferon Type I
Complement Activation
Antimalarials
Butyrophilins
Interferons
Nitric Oxide
Up-Regulation
Inflammation

Keywords

  • antibody responses
  • atypical memory B cells
  • BTNL2
  • experimental cerebral malaria
  • immune response
  • malaria
  • mild malaria
  • mouse model
  • Plasmodium berghei
  • Plasmodium falciparum
  • Rwanda HIV

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy

Cite this

The T-cell inhibitory molecule butyrophilin-like 2 is up-regulated in mild plasmodium falciparum infection and is protective during experimental cerebral malaria. / Subramaniam, Krishanthi S.; Spaulding, Emily; Ivan, Emil; Mutimura, Eugene; Kim, Ryung S.; Liu, Xikui; Dong, Chen; Feintuch, Catherine M.; Zhang, Xingxing; Anastos, Kathryn; Lauvau, Gregoire; Daily, Johanna P.

In: Journal of Infectious Diseases, Vol. 212, No. 8, 15.10.2015, p. 1322-1331.

Research output: Contribution to journalArticle

Subramaniam, Krishanthi S. ; Spaulding, Emily ; Ivan, Emil ; Mutimura, Eugene ; Kim, Ryung S. ; Liu, Xikui ; Dong, Chen ; Feintuch, Catherine M. ; Zhang, Xingxing ; Anastos, Kathryn ; Lauvau, Gregoire ; Daily, Johanna P. / The T-cell inhibitory molecule butyrophilin-like 2 is up-regulated in mild plasmodium falciparum infection and is protective during experimental cerebral malaria. In: Journal of Infectious Diseases. 2015 ; Vol. 212, No. 8. pp. 1322-1331.
@article{054f209ba2b441759a76a84414583ffc,
title = "The T-cell inhibitory molecule butyrophilin-like 2 is up-regulated in mild plasmodium falciparum infection and is protective during experimental cerebral malaria",
abstract = "Plasmodium falciparum infection can result in severe disease that is associated with elevated inflammation and vital organ dysfunction; however, malaria-endemic residents gain protection from lethal outcomes and manifest only mild symptoms during infection. To characterize host responses associated with this more effective antimalarial response, we characterized whole-blood transcriptional profiles in Rwandan adults during a mild malaria episode and compared them with findings from a convalescence sample. We observed transcriptional up-regulation in many pathways, including type I interferon, interferon γ, complement activation, and nitric oxide during malaria infection, which provide benchmarks of mild disease physiology. Transcripts encoding negative regulators of T-cell activation, such as programmed death ligand 1 (PD-L1), programmed death 1 ligand 2 (PD-L2), and the butyrophilin family member butyrophilin-like 2 (BTNL2) were also increased. To support an important functional role for BTNL2 during malaria infection, we studied chimeric mice reconstituted with BTNL2-/- or wild-type hematopoietic cells that were inoculated with Plasmodium berghei ANKA, a murine model of cerebral malaria. We found that BTNL2-/- chimeric mice had a significant decrease in survival compared with wild-type counterparts. Collectively these data characterize the immune responses associated with mild malaria and uncover a novel role for BTNL2 in the host response to malaria.",
keywords = "antibody responses, atypical memory B cells, BTNL2, experimental cerebral malaria, immune response, malaria, mild malaria, mouse model, Plasmodium berghei, Plasmodium falciparum, Rwanda HIV",
author = "Subramaniam, {Krishanthi S.} and Emily Spaulding and Emil Ivan and Eugene Mutimura and Kim, {Ryung S.} and Xikui Liu and Chen Dong and Feintuch, {Catherine M.} and Xingxing Zhang and Kathryn Anastos and Gregoire Lauvau and Daily, {Johanna P.}",
year = "2015",
month = "10",
day = "15",
doi = "10.1093/infdis/jiv217",
language = "English (US)",
volume = "212",
pages = "1322--1331",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - The T-cell inhibitory molecule butyrophilin-like 2 is up-regulated in mild plasmodium falciparum infection and is protective during experimental cerebral malaria

AU - Subramaniam, Krishanthi S.

AU - Spaulding, Emily

AU - Ivan, Emil

AU - Mutimura, Eugene

AU - Kim, Ryung S.

AU - Liu, Xikui

AU - Dong, Chen

AU - Feintuch, Catherine M.

AU - Zhang, Xingxing

AU - Anastos, Kathryn

AU - Lauvau, Gregoire

AU - Daily, Johanna P.

PY - 2015/10/15

Y1 - 2015/10/15

N2 - Plasmodium falciparum infection can result in severe disease that is associated with elevated inflammation and vital organ dysfunction; however, malaria-endemic residents gain protection from lethal outcomes and manifest only mild symptoms during infection. To characterize host responses associated with this more effective antimalarial response, we characterized whole-blood transcriptional profiles in Rwandan adults during a mild malaria episode and compared them with findings from a convalescence sample. We observed transcriptional up-regulation in many pathways, including type I interferon, interferon γ, complement activation, and nitric oxide during malaria infection, which provide benchmarks of mild disease physiology. Transcripts encoding negative regulators of T-cell activation, such as programmed death ligand 1 (PD-L1), programmed death 1 ligand 2 (PD-L2), and the butyrophilin family member butyrophilin-like 2 (BTNL2) were also increased. To support an important functional role for BTNL2 during malaria infection, we studied chimeric mice reconstituted with BTNL2-/- or wild-type hematopoietic cells that were inoculated with Plasmodium berghei ANKA, a murine model of cerebral malaria. We found that BTNL2-/- chimeric mice had a significant decrease in survival compared with wild-type counterparts. Collectively these data characterize the immune responses associated with mild malaria and uncover a novel role for BTNL2 in the host response to malaria.

AB - Plasmodium falciparum infection can result in severe disease that is associated with elevated inflammation and vital organ dysfunction; however, malaria-endemic residents gain protection from lethal outcomes and manifest only mild symptoms during infection. To characterize host responses associated with this more effective antimalarial response, we characterized whole-blood transcriptional profiles in Rwandan adults during a mild malaria episode and compared them with findings from a convalescence sample. We observed transcriptional up-regulation in many pathways, including type I interferon, interferon γ, complement activation, and nitric oxide during malaria infection, which provide benchmarks of mild disease physiology. Transcripts encoding negative regulators of T-cell activation, such as programmed death ligand 1 (PD-L1), programmed death 1 ligand 2 (PD-L2), and the butyrophilin family member butyrophilin-like 2 (BTNL2) were also increased. To support an important functional role for BTNL2 during malaria infection, we studied chimeric mice reconstituted with BTNL2-/- or wild-type hematopoietic cells that were inoculated with Plasmodium berghei ANKA, a murine model of cerebral malaria. We found that BTNL2-/- chimeric mice had a significant decrease in survival compared with wild-type counterparts. Collectively these data characterize the immune responses associated with mild malaria and uncover a novel role for BTNL2 in the host response to malaria.

KW - antibody responses

KW - atypical memory B cells

KW - BTNL2

KW - experimental cerebral malaria

KW - immune response

KW - malaria

KW - mild malaria

KW - mouse model

KW - Plasmodium berghei

KW - Plasmodium falciparum

KW - Rwanda HIV

UR - http://www.scopus.com/inward/record.url?scp=84943388606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943388606&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiv217

DO - 10.1093/infdis/jiv217

M3 - Article

VL - 212

SP - 1322

EP - 1331

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 8

ER -